NVAX - NOVAVAX INC
10.8
0.110 1.019%
Share volume: 5,175,757
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.69
0.11
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-08-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 1.354 B | 1.819 B | 1.712 B | 1.560 B | 1.293 B | 1.337 B | 1.180 B | 1.177 B | |
| Current Assets | 727.120 M | 1.203 B | 1.104 B | 1.129 B | 868.028 M | 919.512 M | 974.590 M | 978.276 M | |
| Inventories | 15.778 M | 9.172 M | 8.638 M | 8.749 M | 10.263 M | 10.240 M | 13.511 M | 11.545 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 369.432 M | 335.901 M | 392.888 M | 468.141 M | 358.560 M | 494.871 M | 494.450 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 480.586 M | 680.162 M | 573.630 M | 530.230 M | 263.338 M | 253.744 M | 268.023 M | 240.634 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 291.093 M | 288.559 M | 285.724 M | 138.413 M | 133.538 M | 129.643 M | 49.120 M | 44.800 M | |
| Other Assets | 335.321 M | 326.717 M | 323.079 M | 293.063 M | 291.426 M | 287.394 M | 156.179 M | 153.436 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.354 B | 1.819 B | 1.712 B | 1.560 B | 1.293 B | 1.337 B | 1.180 B | 1.177 B | |
| Total liabilities | 2.221 B | 2.250 B | 2.239 B | 2.184 B | 1.369 B | 1.299 B | 1.337 B | 1.304 B | |
| Total current liabilities | 804.382 M | 1.158 B | 1.181 B | 1.154 B | 422.170 M | 389.138 M | 429.869 M | 459.950 M | |
| Accounts Payable | 57.724 M | 79.962 M | 57.517 M | 41.579 M | 34.162 M | 50.595 M | 15.227 M | 24.578 M | |
| Other liabilities | 406.331 M | 390.262 M | 373.285 M | 413.340 M | 366.782 M | 339.955 M | 265.752 M | 241.159 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 168.432 M | 168.848 M | 169.265 M | 169.684 M | 170.126 M | 170.568 M | 243.835 M | 244.213 M | |
| Other liabilities | 406.331 M | 390.262 M | 373.285 M | 413.340 M | 366.782 M | 339.955 M | 265.752 M | 241.159 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -867.084 M | -431.706 M | -526.436 M | -623.841 M | -75.643 M | 37.625 M | -156.672 M | -127.753 M | |
| Common stock | 4.206 B | 4.479 B | 4.492 B | 4.503 B | 4.514 B | 4.524 B | 4.533 B | 4.541 B | |
| Retained earnings | -4.969 B | -4.806 B | -4.927 B | -5.008 B | -4.490 B | -4.383 B | -4.586 B | -4.568 B |